|
![]() |
Hermansky-Pudlak SyndromeThis page contains recent news articles, when available, and an overview of Hermansky-Pudlak Syndrome but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Background information on Hermansky-Pudlak Syndrome
Gahl. Hermansky-Pudlak Syndrome-type 3 (HPS-3) is a relatively mild subtype of HPS with minimal cutaneous and ocular depigmentation. ... - Am J Pathology (subscription) InterMune to Release Fourth Quarter and Year-End 2004 Financial ... - Jan 25, 2005 Actimmune. Pirfenidone is being developed for the treatment of IPF and for the treatment of Hermansky-Pudlak Syndrome. Actimmune ... - mysan.de (Pressemitteilung) InterMune Announces Webcast of Corporate Presentation at the ... - Dec 2, 2004 Actimmune. Pirfenidone is being developed for the treatment of IPF and for the treatment of Hermansky-Pudlak Syndrome. Actimmune ... - mysan.de InterMune Announces Second Quarter Financial Results - 29 Jul 2004 Actimmune. Pirfenidone is being developed for the treatment of IPF and for the treatment of Hermansky-Pudlak Syndrome. Actimmune ... - Yahoo News (press release) Business People - Oct 24, 2005 With the award comes a $500 grant from the Allstate Foundation for Hermansky Pudlak Syndrome Network Inc., where Vogt volunteers. ♦ Ruoff Mortgage Co. ... - Fort Wayne News Sentinel Business people Business people - Oct 24, 2005 With this award comes a $500 grant from the Allstate Foundation for Hermansky Pudlak Syndrome Network Inc., where Vogt volunteers. ... - Fort Wayne Journal Gazette Search the web for more resources on Hermansky-Pudlak Syndrome |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2006 MONGABAY.COM |